Li et al. [168] demonstrated a significant correlation between EGFR-TKI treatment sensitivity in non-small cell lung cancer (NSCLC) with CD147-mediated glucose metabolic regulation using (18 F-FDG)-PET/CT imaging. This evidence concerns the gene EGFR and non-small cell lung carcinoma.